ArticleScience translational medicine2014

Regional delivery of mesothelin-targeted CAR T cell therapy generates potent and long-lasting CD4-dependent tumor immunity.

Prasad S Adusumilli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.